.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Farmers Insurance
Federal Trade Commission
Daiichi Sankyo
Julphar
Fuji
Citi
Queensland Health
Healthtrust
UBS

Generated: July 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,061,703

« Back to Dashboard

Summary for Patent: 5,061,703

Title: Adamantane derivatives in the prevention and treatment of cerebral ischemia
Abstract:A method for the prevention and treatment of cerebral ischemia using an adamantane derivative of the formula ##STR1## wherein R.sub.1 and R.sub.2 are identical or different, representing hydrogen or a straight or branched alkyl group of 1 to 6 C atoms or, in conjunction with N, a heterocyclic group with 5 or 6 ring C atoms; wherein R.sub.3 and R.sub.4 are identical or different, being selected from hydrogen, a straight or branched alkyl group of 1 to 6 C atoms, a cycloalkyl group with 5 or 6 C atoms, and phenyl; wherein R.sub.5 is hydrogen or a straight or branched C.sub.1 -C.sub.6 alkyl group, or a pharmaceutically-acceptable salt thereof, is disclosed.
Inventor(s): Bormann; Joachim (Frankfurt, DE), Gold; Markus R. (Nauheim, DE), Schatton; Wolfgang (Eschborn, DE)
Assignee: Merz + Co. GmbH & Co. (Frankfurt am Main, DE)
Application Number:07/508,109
Patent Claim Types:
see list of patent claims
Use; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,061,703

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
89106657Apr 14, 1989

International Patent Family for Patent: 5,061,703

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria94384► Subscribe
Canada2014453► Subscribe
Switzerland679208► Subscribe
German Democratic Republic293493► Subscribe
Germany10299048► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Dow
US Army
Queensland Health
Accenture
Chubb
Johnson and Johnson
Baxter
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot